Home/Filings/4/0000950170-24-095009
4//SEC Filing

Scanlan Sean F. 4

Accession 0000950170-24-095009

CIK 0001630627other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 9:30 PM ET

Size

5.1 KB

Accession

0000950170-24-095009

Insider Transaction Report

Form 4
Period: 2024-08-09
Scanlan Sean F.
Chief Innovation Officer
Transactions
  • Award

    Common Stock

    2024-08-09+120,900216,324 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date.
  • [F2]Includes 215,185 restricted stock units.

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001856371

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 9:30 PM ET
Size
5.1 KB